Intuitive Surgical, Inc.

ISRG Healthcare Medical Instruments & Supplies

Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024.

Revenue
+21.7%
EPS
−24.2%
Free cash flow
+51.0%

Quarter to September 2026, against a year earlier

465.68 16.42 −3.41%
Market cap
$162.4B
P/E
55.7×
Fwd P/E
49.8×
Dividend yield
—
F-score
7/9
Altman Z
50.09
Beneish M
−2.43
Dividend safety
n/a
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
48.64 44.99 55.08 70.71

+8 more quarters

P/S ratio
12.26 12.76 15.46 20.08
P/FCF ratio
38.94 43.08 56.80 81.16
P/Operating CF
115.93 132.72 179.41 226.48
P/B ratio
8.80 7.70 9.30 11.27
EV/Sales
11.91 12.29 15.03 19.49
EV/EBITDA
33.34 31.88 40.20 54.16
EV/FCF
37.84 41.49 55.23 78.77
Current Ratio
3.33 4.96 4.61 4.87
Net Debt/EBITDA
(5.08) (4.37) (4.32) (5.39)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
2.06% 2.22% 1.82% 1.41%
Free Cash Flow Yield
2.57% 2.32% 1.76% 1.23%
Free Cash Flow per Share
3.18 2.68 2.41 2.05
Book value per Share
46.18 51.67 49.58 50.27
Free Cash Flow
1,111.00 948.40 854.60 730.00
EV/EBIT
41.98 39.29 49.36 66.61
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026